G
Genxiang Mao
Publications - 24
Citations - 643
Genxiang Mao is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications receiving 468 citations.
Papers
More filters
Journal ArticleDOI
Frailty syndrome: an overview
TL;DR: Frailty is a common and important geriatric syndrome characterized by age-associated declines in physiologic reserve and function across multiorgan systems, leading to increased vulnerability for adverse health outcomes, including obesity and specific diseases.
Journal ArticleDOI
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Yuyuan Yao,Zhichu Ren,Ruihan Yang,Yilan Mei,Yuying Dai,Qian-Yi Cheng,Chong Xu,Xiaogang Xu,Sanying Wang,Kyoung Mi Kim,Ji Heon Noh,Jian Zhu,Ningwei Zhao,Yong Liu,Genxiang Mao,Jian Sima +15 more
TL;DR: Zhang et al. as discussed by the authors showed that SAL, a potential anti-aging drug candidate, attenuates AD pathology by targeting NRF2/SIRT3 pathway for mitochondrial and neurite protection.
Journal ArticleDOI
mTORC2 Facilitates Liver Regeneration Through Sphingolipid-Induced PPAR-α-Fatty Acid Oxidation
Lingling Zhang,Yanqiu Li,Ying Wang,Yugang Qiu,Han-Chuan Mou,Y.T. Deng,Jiyuan Yao,Zhi-Chao Xia,Wenzhe Zhang,Dina Zhu,Zeyu Qiu,Zhongjie Yu,Jirong Wang,Zhouxin Yang,Genxiang Mao,Dan Chen,Leimin Sun,Lei-Lei Liu,Zhenyu Ju +18 more
TL;DR: In this paper , the peroxisome proliferator-activated receptor α (PPAR-α) agonist, p53 inhibitor, and protein kinase B (AKT) activator were evaluated in the mTORC2-deficient liver.
Journal ArticleDOI
Gracilariopsis lemaneiformis Polysaccharide Attenuates D-Galactose–Induced Aging of Mice by Regulating Oxidative Stress and Gut Microbiota
TL;DR: GP alleviated liver and brain injuries by regulating oxidative stress and modulating the composition and metabolism of the gut microbiota.
Journal ArticleDOI
Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD + bioavailability protecting against steatohepatitis
Weiyan Shen,Xingyong Wan,Jiahui Hou,Zhu Liu,Genxiang Mao,Xiaogang Xu,Chaohui Yu,Xudong Zhu,Zhenyu Ju +8 more
TL;DR: Findings indicate that hepatic-specific overexpression of PGC-1 α exerts a beneficial role in the regulation of steatohepatitis and that pharmacological activation of the SIRT2-PGC-1α-NAD + axis may help to treat NASH.